ArticleBMC oral health2026
Challenges and contributing factors in glucocorticoid treatment adherence among patients with oral lichen planus: a cross-sectional study and management strategies.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the status of glucocorticoid treatment adherence in patients with oral lichen planus (OLP), identify its influencing factors using validated instruments, and propose a targeted management framework incorporating behavioral insights and digital health strategies.
methodsA cross-sectional study was conducted among 116 OLP patients recruited from our hospital between January 2021 and December 2023. The study protocol was approved by the Hospital's Ethics Committee (Approval No: 20201215), and written informed consent was obtained from all participants. Data were collected using a general information questionnaire, the Chinese version of the 8-item Morisky Medication Adherence Scale (MMAS-8), and a self-designed OLP knowledge questionnaire. Exploratory factor analysis was performed to validate the MMAS-8 structure. Multivariate logistic regression was used to identify independent predictors of poor adherence.
resultsThe rate of poor adherence was 63.8% (74/116). Factor analysis confirmed a two-dimensional structure of non-adherence (unintentional and intentional). Multivariate analysis identified age ≥ 50 years, disease duration ≥ 3 years, recurrence frequency ≥ 3, glucocorticoid side effects, and rural residence as independent risk factors for poor adherence (all P < 0.05). Higher education level and household income served as protective factors.
conclusionPoor treatment adherence is prevalent among OLP patients and is influenced by multidimensional factors. The behavioral distinction between unintentional and intentional non-adherence provides a critical basis for precision management. We recommend an integrated strategy combining structured education, side-effect-optimized regimens, and digitally enabled follow-up to address adherence challenges and improve long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.